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Toll-like receptor (TLR)-mediated immune responses
are downregulated by several mechanisms that affect
signaling pathways. However, it remains elusive how
TLR-mediated gene expression is differentially modu-
lated. Here, we show that IkBNS, a TLR-inducible nu-
clear IkB protein, negatively regulates induction of a
subset of TLR-dependent genes through inhibition of
NF-kB activity. IkBNS-deficient macrophages and den-
dritic cells show increased TLR-mediated expression
of genes such as IL-6 and IL-12p40, which are induced
late after TLR stimulation. In contrast, IkBNS-deficient
cells showed normal induction of genes that are in-
duced early or induced via IRF-3 activation. LPS stimu-
lation of IkBNS-deficient macrophages prolonged
NF-kB activity at the specific promoters, indicating
that IkBNS mediates termination of NF-kB activity at
selective gene promoters. Moreover, IkBNS-deficient
mice are highly susceptible to LPS-induced endotoxin
shock and intestinal inflammation. Thus, IkBNS regu-
lates inflammatory responses by inhibiting the induc-
tion of a subset of TLR-dependent genes throughmod-
ulation of NF-kB activity.
Introduction
Toll-like receptors (TLRs) are implicated in the recog-
nition of specific patterns of microbial components
and subsequent induction of gene expression. TLR-
dependent gene expression is induced through acti-
vation of two distinct signaling pathways mediated by
the Toll/IL-1 receptor (TIR) domain-containing adaptors
MyD88 and TRIF. These signaling pathways finally
culminate in the activation of several transcription
factors, such as NF-kB and IRF families (Akira and
Takeda, 2004). The MyD88-dependent gene induction
is achieved by an early phase of NF-kB and IRF-5 acti-
vation in macrophages (Kawai et al., 1999; Takaoka
*Correspondence: ktakeda@bioreg.kyushu-u.ac.jpet al., 2005). The TRIF-dependent gene induction
is mainly regulated by IRF-3 (Sakaguchi et al., 2003;
Yamamoto et al., 2003).
TLR-mediated gene expression regulates activation
of not only innate immunity but also adaptive immunity,
which provides antigen-specific responses against
harmful pathogens (Iwasaki and Medzhitov, 2004; Pa-
sare and Medzhitov, 2004). However, TLR-mediated ac-
tivation of innate immunity, when in excess, triggers de-
velopment of autoimmune disorders and inflammatory
diseases, such as SLE, cardiomyopathy, atherosclero-
sis, diabetes mellitus, and inflammatory bowel diseases
(Bjorkbacka et al., 2004; Eriksson et al., 2003; Kobayashi
et al., 2003; Lang et al., 2005; Leadbetter et al., 2002; Mi-
chelsen et al., 2004). Excessive activation of TLR4 by LPS
induces endotoxin shock, a serious systemic disorder
with a high mortality rate. Therefore, TLR-dependent in-
nate immune responses must be finely regulated, and
underlying mechanisms are now being examined exten-
sively (Liew et al., 2005). Several negative regulators of
TLR-mediated signaling pathways have been proposed.
Cytoplasmic molecules, such as an alternatively spliced
short form of MyD88 (MyD88s), IRAK-M, SOCS1, A20,
PI3-kinase, and TRIAD3A, are all involved in negative
regulation of TLR pathways (Boone et al., 2004; Burns
et al., 2003; Chuang and Ulevitch, 2004; Fukao et al.,
2002; Kinjyo et al., 2002; Kobayashi et al., 2002; Naka-
gawa et al., 2002). Membrane bound SIGIRR, ST2,
TRAILR, and RP105 are also implicated in these pro-
cesses (Brint et al., 2004; Diehl et al., 2004; Divanovic
et al., 2005; Wald et al., 2003).
TLR-dependent gene induction is also regulated by
nuclear IkB proteins, such as IkBz, Bcl-3, and IkBNS.
IkBz is indispensable for positive regulation of a subset
of TLR-dependent genes, such as IL-6 and IL-12p40
(Yamamoto et al., 2004). In contrast, Bcl-3 and IkBNS
seem to be involved in negative regulation of TLR-de-
pendent gene induction. Bcl-3 was shown to be involved
in selective inhibition of TLR-dependent TNF-a produc-
tion (Kuwata et al., 2003; Wessells et al., 2004). An in vitro
study indicated that IkBNS is induced by IL-10 or
LPS and selectively inhibits IL-6 production in macro-
phages (Hirotani et al., 2005). Thus, nuclear IkB proteins
differentially regulate TLR-dependent gene expres-
sion. However, the physiological role of IkBNS is still
unclear.
In this study, we analyzed TLR-dependent inflamma-
tory responses in IkBNS-deficient mice. We found that
IkBNS is involved in selective inhibition of a subset of
MyD88-dependent genes, including IL-6, IL-12p40, and
IL-18. In IkBNS-deficient macrophages, LPS-induced
activation of NF-kB was prolonged. Accordingly, IkBNS-
deficient mice showed increased production of these
cytokines accompanied by high sensitivity to LPS-
induced endotoxin shock. Furthermore, IkBNS-deficient
mice were highly susceptible to intestinal inflammation
caused by disruption of the epithelial barrier. These find-
ings indicate that IkBNS inhibits the induction of a group
of TLR-dependent genes, thereby preventing excessive
inflammation.
Immunity
42Figure 1. Targeted Disruption of the Mouse Ikbns Gene
(A) Maps of the IkBNS wild-type genome, targeting vector, and predicted targeted gene. Open and closed boxes denote the noncoding and cod-
ing exons, respectively. Restriction enzymes: S, ScaI.
(B) Southern blot analysis of offspring from the heterozygote intercrosses. Genomic DNA was extracted from mouse tails, digested with ScaI,
electrophoresed, and hybridized with the probe indicated in (A). The approximate size of the wild-type band is 4.9 kb, and the mutated band is
3.6 kb.
(C) Peritoneal macrophages were cultured with or without 100 ng/ml LPS for 1 hr (L and M, respectively), and total RNA was extracted, electro-
phoresed, transferred to nylon membrane, and hybridized with the mouse IkBNS full-length cDNA probe. The same membrane was rehybridized
with a GAPDH probe.Results
Targeted Disruption of the IkBNS Gene
To study the functional role of IkBNS in TLR-dependent
responses, a null mutation in the Ikbns allele was intro-
duced through homologous recombination in embry-
onic stem (ES) cells (Figures 1A and 1B). IkBNS2/2 mice
were born alive and grew healthy until 20 weeks of
age. We performed Northern blot analysis to confirm
that the mutation causes inactivation of the Ikbns gene.
LPS robustly induced IkBNS mRNA in wild-type macro-
phages, but not in IkBNS2/2 macrophages (Figure 1C).
A previous report indicated that IkBNS is involved in
negative selection of thymocytes (Fiorini et al., 2002).
Therefore, we first analyzed lymphocyte composition
in lymphoid organs such as thymus and spleen by flow
cytometry (Figures S1A and S1B). Total cell number
and CD4/CD8 or CD3/B220 populations in thymus and
spleen were not altered in IkBNS2/2 mice. Splenic
T cells from IkBNS2/2mice showed similar levels of pro-
liferative responses to IL-2 and IL-7 as did wild-type
T cells. Moreover, IkBNS2/2 T cells proliferated to al-
most equal degrees in response to anti-CD3 antibody
compared to wild-type T cells (Figure S1C). These re-
sults indicate that T cell development and functions
were generally unaffected in IkBNS2/2 mice.Increased IL-6 and IL-12p40 Production
in IkBNS-Deficient Cells
Since IkBNS expression was induced within 1 hr of LPS
stimulation in macrophages (Figure 1B), we stimulated
peritoneal macrophages with various concentrations
of LPS and analyzed for production of TNF-a and IL-6
(Figure 2A). In macrophages from IkBNS2/2 mice, LPS-
induced TNF-a production was comparable to wild-type
cells, but IL-6 production was significantly increased.
We then analyzed whether IkBNS2/2 macrophages pro-
duce increased amounts of IL-6 in response to other
TLR ligands, since IkBNS mRNA was induced by several
TLR ligands as well as the TLR4 ligand LPS in a MyD88-
dependent manner (Figure S2A). Peritoneal macro-
phages were stimulated with mycoplasmal lipopeptides
(TLR6 ligand), Pam3CSK4 (TLR1 ligand), peptidoglycan
(TLR2 ligand), and imiquimod (TLR7 ligand), and ana-
lyzed for production of TNF-a and IL-6 (Figure 2B). In re-
sponse to these TLR ligands, the production of IL-6,
but not TNF-a, was increased in IkBNS2/2 mice. We
next analyzed the response of bone marrow-derived
dendritic cells (DCs). DCs from IkBNS2/2mice produced
similar amounts of TNF-a and increased amounts of IL-6
in response to LPS compared to wild-type DCs (Fig-
ure 2C). In addition, DCs showed LPS-induced produc-
tion of IL-12p40 and IL-12p70, and production of these
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43Figure 2. Increased Production of IL-6 and IL-12p40 in IkBNS2/2 Macrophages and Dendritic Cells
(A) Peritoneal macrophages were stimulated with the indicated concentration of LPS for 24 hr. Concentrations of TNF-a and IL-6 in the culture
supernantants were analyzed by ELISA. Data are mean 6 SD of triplicate cultures in a single experiment, representative of three independent
experiments.
(B) Peritoneal macrophages were cultured with 1 or 10 ng/ml of TLR6 ligand (MALP-2), 1 or 10 ng/ml TLR1 ligand (Pam3CSK4), 1 or 10 mg/ml TLR2
ligand (peptidoglycan; PGN), or 1 or 10 mg/ml TLR7 ligand (imiquimod) for 24 hr. Concentrations of TNF-a and IL-6 in the culture supernatants
were analyzed by ELISA. *; not detected.
(C) Bone marrow-derived DCs were stimulated with the indicated concentration of LPS for 24 hr. Concentrations of TNF-a, IL-6, IL-12p40, and
IL-12p70 in the culture supernatants were analyzed by ELISA. Data are mean 6 SD of triplicate cultures in a single experiment, representative
of three independent experiments.cytokines was significantly increased in IkBNS2/2 DCs.
Bone marrow-derived DCs and splenic B cells were
analyzed for LPS-induced surface expression of CD86
or MHC class II (Figure S2B). LPS-induced augmenta-
tion of surface expression of these molecules was not
altered in IkBNS2/2 mice. Thus, macrophages and
DCs from IkBNS2/2 mice showed selective increases
in TLR-dependent production of IL-6 and IL-12p40.
Enhanced Induction of a Subset of TLR-Dependent
Genes in IkBNS-Deficient Macrophages
We further analyzed LPS-induced mRNA expression of
TLR-dependent genes in IkBNS2/2 macrophages. Peri-
toneal macrophages were stimulated with LPS for 1,
3, or 5 hr, and total RNA was extracted. Then, mRNA
expression of TNF-a and IL-6 was first analyzed by
quantitative real-time RT-PCR (Figures 3A and 3B).
LPS-induced TNF-a mRNA expression in IkBNS2/2
macrophages was similar to wild-type cells. In the case
of IL-6 mRNA, expression levels were comparable be-
tween wild-type and IkBNS2/2 macrophages until 3 hr
of LPS stimulation. After 3 hr, IL-6 mRNA levels de-creased in wild-type cells. However, IkBNS2/2 cells dis-
played further enhanced expression of IL-6 mRNA.
TNF-a mRNA was robustly induced within 1 hr of LPS
stimulation, and its expression promptly ceased in wild-
type cells. In contrast, IL-6 mRNA expression was in-
duced late compared to TNF-a. Because LPS-induced
IkBNS mRNA expression showed similar patterns
as TNF-a mRNA, we hypothesized that LPS-inducible
IkBNS blocks mRNA expression of genes that are in-
duced late (Figure 3C). Accordingly, we analyzed mRNA
expression of other genes that are induced early (Il-1b,
Il-23p19, or Ikbz) or late (Il-12p40, Il-18, or Csf3) in re-
sponse to LPS. LPS-induced mRNA expression of Il-1b
(IL-1b), Il-23p19 (IL-23p19), and Ikbz (IkBz) was similarly
observed between wild-type and IkBNS2/2 macro-
phages (Figure 3A). LPS-induced expression of Il-
12p40 (IL-12p40), Il-18 (IL-18) and Csf3 (G-CSF) was ob-
served at normal levels in IkBNS2/2 macrophages at
the early phase of LPS stimulation (within 3 hr of LPS
stimulation) (Figure 3B). However, at the late phase of
LPS stimulation (after 3 hr of LPS stimulation), mRNA ex-
pression of these genes was significantly enhanced in
Immunity
44Figure 3. LPS-Induced Expression of Several TLR-Dependent Genes in IkBNS2/2 Macrophages
Peritoneal macrophages from wild-type and IkBNS2/2 mice were stimulated with 100 ng/ml LPS for the indicated periods. Total RNA was ex-
tracted, and then subjected to quantitative real-time RT-PCR analysis using primers specific for Tnf, Il-1b, Il-23p19, Ikbz (A), Il-6, Il-12p40,
Il-18, Csf3 (B), Ikbns (C), Cxcl10, Ccl2, Ccl5 (D), and Il-10 (E). The fold difference of each sample relative to EF-1a levels is shown. Representative
of three independent experiments.IkBNS2/2 cells. We also analyzed LPS-induced expres-
sion ofCxcl10 (IP-10),Ccl2 (MCP-1), andCcl5 (RANTES),
which are induced by the TRIF-dependent activation of
IRF-3 (Figure 3D). LPS-induced expression of these
genes was not altered in IkBNS2/2 macrophages. An
anti-inflammatory cytokine IL-10 is induced by TLR
stimulation and thereby inhibits TLR-dependent gene
induction (Moore et al., 2001). Therefore, we next ad-
dressed LPS-induced IL-10 mRNA expression (Fig-
ure 3E). LPS-induced IL-10 mRNA expression was com-
parable between wild-type and IkBNS2/2macrophages.
In addition, LPS-induced production of IL-10 protein
was not compromised in IkBNS2/2 DCs (Figure S2C).
These findings indicate that the enhanced LPS-induced
expression of a subset of TLR-dependent genes was not
due to the impaired IL-10 production in IkBNS2/2 mice.
Prolonged NF-kB Activity in IkBNS-Deficient Cells
Gene expression of Cxcl10 (IP-10), Ccl2 (MCP-1), and
Ccl5 (RANTES) was mainly regulated by the transcriptionfactor IRF-3 in the TRIF-dependent pathway, whereas
TNF-a, IL-6, and IL-12p40 gene expression was mainly
regulated by the MyD88-dependent activation of NF-kB
(Akira and Takeda, 2004; Yamamoto et al., 2003). In addi-
tion, previous in vitro studies indicated that overexpres-
sion of IkBNS leads to compromised NF-kB activity
through selective association of IkBNS with p50 subunit
of NF-kB (Fiorini et al., 2002; Hirotani et al., 2005). There-
fore, we next analyzed LPS-induced activation of NF-kB.
LPS-induced degradation of IkBawas not compromised
in IkBNS2/2macrophages (Figure S3A). Next, peritoneal
macrophages or bone marrow-derived macrophages
were stimulated with LPS and DNA binding activity was
analyzed by EMSA (Figure 4A; Figure S3B). LPS stimula-
tion resulted in enhanced DNA binding activity of NF-kB
in both wild-type and IkBNS2/2 macrophages to similar
extents within 1 hr. After 1 hr of LPS stimulation, NF-kB
activity decreased in wild-type cells. However, NF-kB
activity sustained and even at 3 hr of LPS stimulation
significant DNA binding activity was still observed in
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45Figure 4. Persistent LPS-Induced Activation of NF-kB in IkBNS2/2 Macrophages
(A) Peritoneal macrophages from wild-type and IkBNS2/2 mice were stimulated with 100 ng/ml LPS. At the indicated time points, nuclear ex-
tracts were prepared, and NF-kB activation was analyzed by EMSA using a NF-kB specific probe.
(B) Peritoneal macrophages were stimulated with LPS. At the indicated time points, nuclear fractions were isolated and subjected to Western
blotting using anti-p65 Ab, anti-p50 Ab, anti-cRel Ab, or anti-polII Ab.
(C) Macrophages were stimulated with LPS for the indicated periods. Then, cells were stained with anti-p65 Ab or anti-p50 Ab (red) as well as
DAPI (blue), and analyzed by confocal microscopy. Merged images are shown.IkBNS2/2 cells. We next analyzed nuclear localization of
NF-kB subunits. Peritoneal macrophages were stimu-
lated with LPS for the indicated periods, and nuclear
fractions were analyzed for expression of p65, p50, and
c-Rel by immunoblotting (Figure 4B). In wild-type macro-
phages, nuclear translocation of p65 was observed
within 30 min of LPS stimulation, and nuclear localized
p65 gradually decreased thereafter. In contrast, nuclear
localized p65 was still significantly observed even at 3 hr
of LPS stimulation in IkBNS2/2 cells. In addition, sus-
tained nuclear localization of p50, but not c-Rel, was ob-
served in IkBNS2/2 macrophages (Figure 4B). Nuclear
localization of NF-kB subunits was also analyzed by im-
munofluorescent staining of macrophages (Figure 4C).
Without stimulation, p65 and p50 were localized in the
cytoplasm, but not in the nucleus, in both wild-type
and IkBNS2/2 macrophages. LPS stimulation resulted
in nuclear staining of both p65 and p50 at 1 hr. Nuclear
staining of p65 and p50 gradually decreased after 1 hr
of LPS stimulation and was only faintly observed at 2 hr
of stimulation in wild-type cells. However, nuclear local-
ization of p65 and p50 was still evident at 2 hr of LPS stim-
ulation in IkBNS2/2 cells. These findings indicate that
LPS-induced NF-kB activity was prolonged in IkBNS2/2
macrophages. NF-kB activity is terminated by degrada-
tion of promoter-bound p65 (Natoli et al., 2005; Saccani
et al., 2004). We used RAW264.7 macrophage cell line
and performed pulse-chase experiments with 35S-la-
beled amino acids to analyze p65 turnover (Figure S3C).
In these cells, labeled p65 was accumulated into the nu-
cleus until 2 hr of LPS stimulation, and then p65 was de-
graded. In RAW cells constitutively expressing IkBNS,
nuclear accumulation of labeled p65 was similarly ob-
served until 1 hr of LPS stimulation. However, the p65
turnover was observed more rapidly and labeled p65disappeared at 2 hr after LPS stimulation (Figure S3C).
These findings indicate that IkBNS mediates the degra-
dation of p65. The MyD88-dependent pathway mediates
activation of MAP kinase cascades as well as NF-kB
activation. Therefore, LPS-induced phosphorylation of
p38, ERK1, ERK2, and JNK was analyzed by Western
blotting (Figure S3D). LPS-induced activation of these
MAP kinases was not compromised in IkBNS2/2macro-
phages.
Regulation of p65 Activity at the IL-6 Promoter
by IkBNS
We next addressed how IkBNS selectively downregu-
lates induction of genes that are induced late. We uti-
lized the IL-6 and TNF-a promoters, which are represen-
tatives of genes activated late and early, respectively.
Wild-type macrophages were stimulated with LPS and
analyzed for recruitment of endogenous IkBNS to the
promoters by chromatin immunoprecipitation (ChIP) as-
say (Figure 5A). Consistent with previous findings using
IkBNS overexpressing macrophage cell lines (Hirotani
et al., 2005), endogenous IkBNS was recruited to the
IL-6 promoter, but not the TNF-a promoter, in LPS-stim-
ulated macrophages. We next addressed LPS-induced
recruitment of p65 to the promoters in wild-type and
IkBNS2/2 macrophages (Figure 5B). Recruitment of
p65 to the TNF-a promoter peaked at 1 hr of LPS stimu-
lation and gradually decreased thereafter in a similar
manner in both wild-type and IkBNS2/2 cells. Recruit-
ment of p65 to the IL-6 promoter was observed to similar
extents until 3 hr of LPS stimulation in wild-type and
IkBNS2/2 macrophages. After that, it decreased in wild-
type macrophages. In contrast, p65 recruitment was still
evident, rather enhanced, even after 5 hr of LPS stim-
ulation in IkBNS2/2 macrophages. Thus, p65 activity at
Immunity
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the IL-6 Promoter
(A) Wild-type bone marrow-derived macro-
phages were stimulated with 100 ng/ml of
LPS for the indicated periods, and chromatin
immunoprecipitation (ChIP) assay was per-
formed with anti-IkBNS Ab or control Ig. The
immunoprecipitated TNF-a promoter (upper
panel) or IL-6 promoter (lower panel) was an-
alyzed by PCR with promoter-specific pri-
mers. PCR amplification of the total input
DNA in each sample is shown (Input). Repre-
sentative of three independent experiments.
The same result was obtained when perito-
neal macrophages were used.
(B) Macrophages from wild-type or IkBNS2/2
mice were stimulated with LPS for the indi-
cated periods. Then, ChIP assay was per-
formed with anti-p65 Ab or control Ig. The im-
munoprecipitated TNF-a promoter (upper
panel) or IL-6 promoter (lower panel) was an-
alyzed by PCR with promoter-specific pri-
mers. Representative of three independent
experiments.the IL-6 promoter, but not at the TNF-a promoter, was
prolonged in LPS-stimulated IkBNS2/2 macrophages.
Taken together, these findings indicate that TLR-induc-
ible IkBNS is responsible for termination of NF-kB activ-
ity through its recruitment to specific promoters.
High Sensitivity to LPS-Induced Endotoxin Shock
in IkBNS-Deficient Mice
To study the in vivo role of IkBNS, we examined LPS-in-
duced endotoxin shock. Intraperitoneal injection of LPS
resulted in marked increases in serum concentrations of
TNF-a, IL-6, and IL-12p40 (Figure 6A). TNF-a level was
comparable between wild-type and IkBNS2/2 mice,
which rapidly peaked at around 1.5 hr of LPS administra-
tion. In the case of IL-6 and IL-12p40 levels, concentra-
tions of both cytokines were almost equally elevated
within 3 hr of LPS injection. After 3 hr, levels of both cy-
tokines gradually decreased in wild-type mice. How-
ever, concentrations of IL-6 and IL-12p40 sustained,
rather enhanced, in IkBNS2/2 mice after 3 hr. Thus, per-
sistently high concentrations of LPS-induced serum IL-6
and IL-12p40 were observed in IkBNS2/2 mice. Further-
more, high sensitivity to LPS-induced lethality was ob-
served in IkBNS2/2 mice (Figure 6B). All IkBNS2/2
mice died within 4 days of LPS challenge at a dose of
which almost all wild-type mice survived over 4 days.
These findings indicate that IkBNS2/2 mice are highly
sensitive to LPS-induced endotoxin shock.High Susceptibility to DSS-Induced Colitis
in IkBNS2/2 Mice
In a previous report, IkBNS was shown to be constitu-
tively expressed in macrophages residing in the colonic
lamina propria, which explains one of the mechanisms
for hyporesponsiveness to TLR stimulation in these cells
(Hirotani et al., 2005). Therefore, we next stimulated
CD11b+ cells isolated from the colonic lamina propria
with LPS and analyzed for production of TNF-a and IL-
6 (Figure S4). In CD11b+ cells from wild-type mice,
LPS-induced production of these cytokines was not sig-
nificantly observed. In cells from IkBNS2/2 mice, IL-6
production was increased even in the absence of stimu-
lation, and LPS stimulation led to markedly enhanced
production of IL-6, but not TNF-a. In the next experi-
ment, in order to expose these cells to microflora and
cause intestinal inflammation, mice were orally adminis-
tered with dextran sodium sulfate (DSS), which is toxic
to colonic epithelial cells and therefore disrupts the ep-
ithelial cell barrier (Kitajima et al., 1999). IkBNS2/2 mice
showed more severe weight loss compared with wild-
type mice (Figure 7A). Histological analyses of the colon
indicated that the inflammatory lesions were more se-
vere and more extensive in IkBNS2/2 mice (Figures 7B
and 7C). Thus, IkBNS2/2 mice are highly susceptible to
intestinal inflammation. Th1-oriented CD4+ T cell re-
sponse was shown to be associated with DSS colitis
(Strober et al., 2002). Therefore, we analyzed IFN-g
Inhibition of a Set of TLR-Induced Genes by IkBNS
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Age-matched wild-type (n = 6) and IkBNS2/2 (n = 6) mice were intraperitoneally injected with LPS (1 mg). (A) Sera were taken at 1.5, 3, 6, and 9 hr
after LPS injection. Serum concentrations of TNF-a, IL-6, and IL-12p40 were determined by ELISA. Results are shown as mean 6 SD of serum
samples from six mice. (B) Survival was monitored for 5 days.production from splenic CD4+ T cells of wild-type and
IkBNS2/2 mice before and after DSS administration
(Figure 7D). DSS administration led to a mild increase
in IFN-g production in wild-type mice. In nontreated
IkBNS2/2mice, IFN-g production was slightly increased
compared with nontreated wild-type mice. In DSS-fed
IkBNS2/2 mice, a significant increase in IFN-g produc-
tion was observed compared to DSS-fed wild-type mice.
These results indicate that IkBNS2/2 mice are suscepti-
ble to intestinal inflammation caused by exposure to
microflora.
Discussion
In the present study, we characterized the physiological
function of IkBNS. Induced by TLR stimulation, IkBNS is
involved in termination of NF-kB activity and thereby in-
hibits a subset of TLR-dependent genes that are in-
duced late through MyD88-dependent NF-kB activation.
Accordingly, IkBNS2/2mice show sustained production
of IL-6 and IL-12p40, resulting in high susceptibility to
LPS-induced endotoxin shock. Furthermore, IkBNS2/2
mice are susceptible to intestinal inflammation accom-
panied by enhanced Th1 responses.
IkBNS was originally identified as a molecule that me-
diates negative selection of thymocytes (Fiorini et al.,
2002). However, IkBNS2/2mice did not show any defect
in T cell development. Requirement of IkBNS in negative
selection of thymocytes should be analyzed preciselyusing peptide-specific TCR transgenic mice, such as
mice bearing the H-Y TCR, in the future (Kisielow et al.,
1988).
Recent studies have established that TLR-dependent
gene induction is regulated mainly by NF-kB and IRF
families of transcription factors (Akira and Takeda,
2004; Honda et al., 2005; Takaoka et al., 2005). In TLR4
signaling, the TRIF-dependent pathway is responsible
for induction of IFN-b and IFN-inducible genes through
activation of IRF-3, whereas the MyD88-dependent
pathway mediates induction of several NF-kB depen-
dent genes (Beutler, 2004). A study with mice lacking
IkBz, another member of nuclear IkB proteins, has dem-
onstrated that the MyD88-dependent genes are divided
into at least two types; one is induced early and inde-
pendent of IkBz, and another is induced late and depen-
dent on IkBz (Yamamoto et al., 2004). The IkBz-regu-
lated genes include IL-6, IL-12p40, IL-18, and G-CSF,
which are all upregulated in LPS-stimulated IkBNS2/2
macrophages. Thus, IkBNS seems to possess a function
quite opposite to IkBz. IkBNS is most structurally related
to IkBz (Fiorini et al., 2002; Hirotani et al., 2005). But, IkBz
has an additional N-terminal structure, which seemingly
mediates the induction of target genes (Motoyama et al.,
2005). Thus, nuclear IkB proteins IkBz and IkBNS posi-
tively and negatively regulate a subset of TLR-induced
NF-kB-dependent genes, respectively.
Recently, negative regulation of TLR-dependent gene
induction was extensively analyzed (Liew et al., 2005).
Immunity
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(A) Wild-type (n = 15) and IkBNS2/2mice (n = 15) were given 1.5% DSS in drinking water for 6 days and weighed everyday. Data are mean6 SD. *,
p < 0.05.
(B) Histologic examination of the colons of wild-type and IkBNS2/2 mice before or 9 days after initiation of DSS administration. H&E staining is
shown. Representative of six mice examined. Magnification, 203.
(C) The colitis scores shown for individual wild-type (circle) and IkBNS2/2mice (square) before (open) and after (closed) DSS treatment were total
scores for individual sections as described in the Experimental Procedures section. Mean score for each group is also shown (black bar).
(D) CD4+ T cells were purified from spleen of wild-type or IkBNS2/2mice either treated or nontreated with DSS. Then, CD4+ T cells were cultured
in the presence or absence of plate bound anti-CD3 Ab for 24 hr. Concentration of IFN-g in the culture supernatants was measured by ELISA.So far, characterized negative regulators are mainly in-
volved in blockade of TLR signaling pathways in the cy-
toplasm or on the cell membrane. Accordingly, these
negative regulators globally inhibit TLR-dependent
gene induction. The nuclear IkB protein IkBNS is unique
in that this molecule negatively regulates induction of
a set of TLR-dependent genes by directly affecting
NF-kB activity in the nucleus. Thus, TLR-dependent in-
nate immune responses are regulated through a variety
of mechanisms.
IkBNS-mediated inhibition of a set of TLR-dependent
genes is probably explained by recruitment of IkBNS to
the specific promoters. IkBNS was recruited to the IL-6
promoter, but not to the TNF-a promoter. In addition,
LPS-induced recruitment of p65 to the TNF-a promoter
was observed within 1 hr, whereas p65 recruitment to
the IL-6 promoter was observed late, indicating that
NF-kB activity was differentially regulated at both pro-
moters. NF-kB activity at the TNF-a promoter is regu-
lated in an IkBNS-independent manner, whereas the
activity at the IL-6 promoter was IkBNS-dependent. In-
deed, p65 recruitment to the TNF-a promoter was ob-served similarly in wild-type and IkBNS2/2 macro-
phages, but the recruitment to the IL-6 promoter was
sustained in IkBNS2/2 cells. Previous reports indicate
that IkBNS selectively associates with p50 subunit of
NF-kB and affects NF-kB DNA binding activity (Fiorini
et al., 2002; Hirotani et al., 2005). Consistent with these
observations, IkBNS2/2 macrophages showed pro-
longed LPS-induced NF-kB DNA binding activity and
nuclear localization of p65. Taken together, these find-
ings indicate that IkBNS, which is rapidly induced by
TLR stimulation, might be recruited to gene promoters
through association with p50, and contribute to termina-
tion of NF-kB activity. Termination of NF-kB activity has
been shown to be induced by IKKa-mediated degrada-
tion of promoter-bound p65 (Lawrence et al., 2005).
However, consistent with a recent report, we were not
able to detect LPS-induced degradation of p65 in perito-
neal macrophages and bone marrow-derived macro-
phages (Li et al., 2005). However, we could detect
LPS-induced p65 degradation in the RAW264.7 macro-
phage cell line. In these cells, when constitutively
expressed IkBNS, LPS-induced p65 turnover was
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49accelerated, indicating that IkBNS is involved in the deg-
radation of promoter-bound p65. In the case of the
TNF-a promoter, it is possible that NF-kB activity is al-
ready terminated when IkBNS expression is induced,
and therefore IkBNS is no longer recruited to the
TNF-a promoter. Alternatively, an unidentified mecha-
nism that regulates selective recruitment of IkBNS to
gene promoters might exist. The mechanisms by which
IkBNS is recruited to the specific promoters through as-
sociation with p50 remain unclear and would be a sub-
ject of further investigation.
Analyses of IkBNS2/2 mice further highlighted the
in vivo functions of IkBNS in limiting systemic and intes-
tinal inflammation. IkBNS2/2 mice succumbed to sys-
temic LPS-induced endotoxin shock possibly due to
sustained production of several TLR-dependent gene
products such as IL-6 and IL-12p40. Furthermore,
IkBNS2/2mice are more susceptible to intestinal inflam-
mation induced by disruption of the epithelial barrier.
Abnormal activation of innate immune cells caused by
deficiency of IL-10 or Stat3 leads to spontaneous devel-
opment of colonic inflammation (Kobayashi et al., 2003;
Kuhn et al., 1993; Takeda et al., 1999). IkBNS2/2 mice
did not develop chronic colitis spontaneously until 20
week-old of age (our unpublished data). In Stat3 mutant
mice, TLR-dependent production of proinflammatory
cytokines increased over 10-fold compared to wild-
type cells, which might contribute to the spontaneous in-
testinal inflammation (Takeda et al., 1999). In IkBNS2/2
mice, increase in TLR-dependent production of proin-
flammatory cytokines such as IL-6 and IL-12p40 was
mild compared to Stat3 mutant mice. In this case, the co-
lonic epithelial barrier might contribute to prevention of
excessive inflammatory responses in IkBNS2/2 mice.
However, when the barrier function of epithelial cells
was disrupted by administration of DSS, IkBNS2/2
mice suffered from severe intestinal inflammation ac-
companied by enhanced Th1 responses. IkBNS was
shown to be expressed in CD11b+ cells residing in the
colonic lamina propria (Hirotani et al., 2005). Therefore,
in the absence of IkBNS, exposure of innate immune
cells to intestinal microflora might result in increased or
sustained production of proinflammatory cytokines such
as IL-12p40, which induces exaggerated intestinal in-
flammation and Th1 cell development. Thus, IkBNS is re-
sponsible for the prevention of uncontrolled inflamma-
tory responses in vivo.
In this study, we have shown that IkBNS is a selective
inhibitor of TLR-dependent genes possibly through ter-
mination of NF-kB activity. Furthermore, IkBNS was re-
sponsible for prevention of inflammation through inhibi-
tion of persistent proinflammatory cytokine production.
Future study that discloses the precise molecular mech-
anisms by which the nuclear IkB protein selectively in-
hibits TLR-dependent genes will provide basis for the
development of new therapeutic strategies to a variety
of inflammatory diseases.
Experimental Procedures
Generation of IkBNS-Deficient Mice
The Ikbns gene consists of eight exons (Figure 1A). The targeting
vector was designed to replace a 1.8 kb fragment containing exons
5–8 of the Ikbns gene with a neomycin-resistance gene (neo). A shortarm and a long arm of the homology region from the E14.1 ES ge-
nome were amplified by PCR. A herpes simplex virus thymidine ki-
nase gene (HSV-TK) was inserted into the 30 end of the vector. After
the targeting vector was electroporated into ES cells, G418 and gan-
cyclovir doubly resistant clones were selected and screened for ho-
mologous recombination by PCR and verified by Southern blot anal-
ysis using the probe indicated in Figure 1A. Two independently
identified targeted ES clones were microinjected into C57BL/6 blas-
tocysts. Chimeric mice were mated with C57BL/6 female mice, and
heterozygous F1 progenies were intercrossed to obtain IkBNS2/2
mice. Mice from these independent ES clones displayed identical
phenotypes. All animal experiments were conducted according to
guidelines of Animal Care and Use Committee at Kyushu University.
Reagents
LPS (E. coli 055:B5) was purchased from Sigma. Peptidoglycan was
from Fluca. Pam3CSK4, MALP-2, and imiquimod were from Invivo-
gen. Antibodies against p65 (C-20; sc-372), p50 (H-119; sc-7178 or
NLS; sc-114), c-Rel (C; sc-71), and RNA polymerase II (H-224;
sc-9001) were purchased from Santa Cruz. Rabbit anti-IkBNS
Ab was generated against synthetic peptide (1-MEDSLDTRLY
PEPSLSQVC-18) corresponding to N-terminal region of mouse
IkBNS (MBL, Nagoya, Japan), and anti-IkBNS serum was affinity-pu-
rified using a column containing peptide-conjugated Sepharose 4B.
Preparation of Macrophages and Dendritic Cells
For isolation of peritoneal macrophages, mice were intraperitoneally
injected with 2 ml of 4% thioglycollate medium (Sigma). Peritoneal
exudate cells were isolated from the peritoneal cavity 3 days post in-
jection. Cells were incubated for 2 hr and washed three times with
HBSS. Remaining adherent cells were used as peritoneal macro-
phages for the experiments. To prepare bone marrow-derived mac-
rophages, bone marrow cells were prepared from femora and tibia
and passed through nylon mesh. Then cells were cultured in RPMI
1640 medium supplemented with 10% FCS, 100 mM 2-ME, and 10
ng/ml M-CSF (GenzymeTechne). After 6–8 days, the cells were
used as macrophages for the experiments. Bone marrow-derived
DCs were prepared by culturing bone marrow cells in RPMI 1640
medium supplemented with 10% FCS, 100 mM 2-ME, and 10 ng/ml
GM-CSF (GenzymeTechne). After 6 days, the cells were used as
DCs.
Measurement of Cytokine Production
Peritoneal macrophages or DCs were stimulated with various TLR li-
gands for 24 hr. Culture supernatants were collected and analyzed
for TNF-a, IL-6, IL-12p40, IL-12p70, or IL-10 production with en-
zyme-linked immunosorbent assay (ELISA). Mice were intrave-
nously injected with 1mg of LPS and bled at the indicated periods.
Serum concentrations of TNF-a, IL-6, and IL-12p40 were determined
by ELISA. ELISA kits were purchased from GenzymeTechne and
R&D Systems. For measurement of IFN-g, CD4+ T cells were purified
from spleen cells using CD4 microbeads (Miltenyi Biotec) and stim-
ulated by plate bound anti-CD33 antibody (145-2C11, BD PharMin-
gen) for 24 hr. Concentrations of IFN-g in the supernatants were de-
termined by ELISA (GenzymeTechne).
Quantitative Real-Time RT-PCR
Total RNA was isolated with TRIzol reagent (Invitrogen, Carlsbad,
CA), and 2 mg of RNA was reverse transcribed using M-MLV reverse
transcriptase (Promega, Madison, WI) and oligo (dT) primers
(Toyobo, Osaka, Japan) after treatment with RQ1 DNase I (Promega).
Quantitative real-time PCR was performed on an ABI 7700 (Applied
Biosystems, Foster City, CA) using TaqMan Universal PCR Master
Mix (Applied Biosystems). All data were normalized to the corre-
sponding elongation factor-1a (EF-1a) expression, and the fold dif-
ference relative to the EF-1a level was shown. Amplification condi-
tions were: 50ºC (2 min), 95ºC (10 min), 40 cycles of 95ºC (15 s), and
60ºC (60 s). Each experiment was performed independently at least
three times, and the results of one representative experiment are
shown. All primers were purchased from Assay on Demand (Applied
Biosystems).
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Macrophages were stimulated with 100 ng/ml LPS for the indicated
periods. Then, nuclear proteins were extracted, and incubated with
an end-labeled, double-stranded oligonucleotide containing an NF-
kB binding site of the IL-6 promoter in 25 ml of binding buffer (10 mM
HEPES-KOH, [pH 7.8], 50 mM KCl, 1 mM EDTA [pH 8.0], 5 mM MgCl2
and 10% glycerol) for 20 min at room temperature and loaded on
a native 5% polyacrylamide gel. The DNA-protein complexes were
visualized by autoradiography.
Western Blotting
Cells were lysed with RIPA buffer (50 mM Tris-HCl [pH 7.5], 150 mM
NaCl, 1% Triton X-100, 0.5% Na-deoxycholate) containing protease
inhibitors (Complete Mini; Roche). The lysates were separated on
SDS-PAGE and transferred to PVDF membrane. The membranes
were incubated with anti-IkBa Ab, anti-ERK Ab, anti-p38 Ab, anti-
JNK Ab (Santa Cruz Biotechnology), anti-phospho-p38 Ab, anti-
phospho-ERK Ab, or anti-phospho-JNK Ab (Cell Signaling Tech-
nology). Bound Abs were detected with SuperSignal West Pico
Chemiluminescent Substrate (Pierce).
Immunofluorescence Staining
Macrophages were stimulated with 100 ng/ml LPS for the indicated
periods, washed with Tris-buffered saline (TBS), and fixed with 3.7%
formaldehyde in TBS for 15 min at room temperature. After perme-
abilization with 0.2% Triton X-100, cells were washed with TBS
and incubated with 10 ng/ml of a rabbit anti-p50 or anti-p65 Ab
(Santa Cruz Biotechnology) in TBS containing 1% bovine serum al-
bumin, followed by incubation with Alexa Fluor 594-conjugated goat
anti-rabbit immunoglobulin G (IgG; Molecular Probes, Eugene, OR).
To stain the nucleus, cells were cultured with 0.5 mg/ml 4, 6-diami-
dino-2-phenylindole (DAPI; Wako, Osaka, Japan). Stained cells
were analyzed using an LSM510 model confocal microscope (Carl
Zeiss, Oberkochem, Germany).
Chromatin Immunoprecipitation
Chromatin immunoprecipitation (ChIP) was performed essentially
with a described protocol (Upstate Biotechnology, Lake Placid,
NY). In brief, peritoneal macrophages from wild-type and IkBNS2/2
mice were stimulated with 100 ng/ml LPS for 1, 3, or 5 hr, and
then fixed with formaldehyde for 10 min. The cells were lysed,
sheared by sonication using Bioruptor (CosmoBio), and incubated
overnight with specific antibody followed by incubation with protein
A-agarose saturated with salmon sperm DNA (Upsate Biotechnol-
ogy). Precipitated DNA was analyzed by quantitative PCR (35 cycles)
using primers 50- CCCCAGATTGCCACAGAATC -30 and 50- CCAGT
GAGTGAAAGGGACAG -30 for the TNF-a promoter and 50- TGTGTG
TCGTCTGTCATGCG-30 and 50- AGCTACAGACATCCCCAGTCTC -30
for the IL-6 promoter.
Induction of DSS Colitis
Mice received 1.5% (wt/vol) DSS (40,000 kDa; ICN Biochemicals), ad
libitum, in their drinking water for 6 days, then switched to regular
drinking water. The amount of DSS water drank per animal was re-
corded and no differences in intake between strains were observed.
Mice were weighed for the determination of percent weight change.
This was calculated as: percentage weight change = (weight at day
X-day 0/weight at day 0) 3 100. Statistical significance was deter-
mined by paired Student’s t test. Differences were considered to
be statistically significant at p < 0.05.
Histological Analysis
Colon tissues were fixed in 4% paraformaldehyde, rolled up, and
embedded in paraffin in a Swiss roll orientation such that the entire
length of the intestinal tract could be identified on single sections.
After sectioning, the tissues were dewaxed in ethanol, rehydrated,
and stained hematoxylin and eosin to study histological changes af-
ter DSS-induced damage. Histological scoring was performed in
a blinded fashion by a pathologist, with a combined score for inflam-
matory cell infiltration (score, 0–3) and tissue damage (score, 0–3)
(Araki et al., 2005). The presence of occasional inflammatory cells
in the lamina propria was assigned a value of 0; increased numbers
of inflammatory cells in the lamina propria as 1; confluence of inflam-
matory cells, extending into the submucosa, as 2; and transmuralextension of the infiltrate as 3. For tissue damage, no mucosal dam-
age was scored as 0; discrete lymphoepithelial lesions were scored
as 1; surface mucosal erosion or focal ulceration was scored as 2;
and extensive mucosal damage and extension into deeper struc-
tures of the bowel wall were scored as 3. The combined histological
score ranged from 0 (no changes) to 6 (extensive cell infiltration and
tissue damage).
Supplemental Data
Supplemental Data include four figures and are available with this
article online at http://www.immunity.com/cgi/content/full/24/1/
41/DC1/.
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